BIOTEK, INC.

Basic Information

21-C OLYMPIA AVENUE
WOBURN, MA, 01801

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Vaginal Bioprotection by Controlled Acidification

    Amount: $861,833.00

    DESCRIPTION (provided by applicant): A single unobtrusive product capable of protecting women against both disease and pregnancy should gain widespread acceptance. BIOTEK is investigating a new vagina ...

    SBIR Phase II 2004 Department of Health and Human Services
  2. Transdermal Buprenorphine for Opiate Antagonist Therapy

    Amount: $765,206.00

    DESCRIPTION (provided by applicant): Opiate antagonist therapy is an important treatment for recently withdrawn opiate addicts. Buprenorphine is a mixed agonist-antagonist which eliminates physiologic ...

    SBIR Phase II 2004 Department of Health and Human Services
  3. Microlayered Erythropoietin Implants

    Amount: $99,975.00

    DESCRIPTION (provided by applicant): BIOTEK has discovered a unique processing method for the efficient and safe formulation of peptides or proteins in polylactide-co-glycolide (PLGA) polymer for long ...

    SBIR Phase I 2003 Department of Health and Human Services
  4. TRANSDERMAL BUPRENORPHINE FOR OPIATE ANTAGONIST THERAPY

    Amount: $99,876.00

    DESCRIPTION (provided by applicant): Opiate antagonist therapy is an important treatment for recently withdrawn narcotic addicts. Buprenorphine is a drug with mixed agonist-antagonist properties, whic ...

    SBIR Phase I 2002 Department of Health and Human Services
  5. BUPRENORPHINE MICROCAPSULES FOR HEROIN ADDICTION

    Amount: $99,965.00

    DESCRIPTION (provided by applicant): The overall objective of the program is to develop a new more economical sustained action injectable formulation of -buprenorphine, based on micro ...

    SBIR Phase I 2002 Department of Health and Human Services
  6. INNOVATIVE SINGLE-DOSE HEPATITIS B VACCINE FORMULATION

    Amount: $96,565.00

    DESCRIPTION (provided by applicant): Hepatitis B (HBV) is a serious viral disease that can result in acute massive hepatic necrosis, chronic active hepatitis, and cirrhosis of the liver. HBV vaccines ...

    SBIR Phase I 2002 Department of Health and Human Services
  7. A ONE YEAR ESTROGEN/PROGESTIN IMPLANT

    Amount: $0.00

    This program targets a one-year biodegradable estrogen/progestin implant for postmenopausal hormone replacement therapy. Estradiol plus levonorgestrel will be incorporated into an innovative implant d ...

    SBIR Phase I 2002 Department of Health and Human Services
  8. A ONE YEAR ESTROGEN/PROGESTIN IMPLANT

    Amount: $744,898.00

    This program targets a one-year biodegradable estrogen/progestin implant for postmenopausal hormone replacement therapy. Estradiol plus levonorgestrel will be incorporated into an innovative implant d ...

    SBIR Phase II 2002 Department of Health and Human Services
  9. A NEW METHOD FOR TREATING SLEEP DISORDERS

    Amount: $494,477.00

    DESCRIPTION (provided by applicant): BIOTEK has developed a transdermal melatonin formulation capable of producing flux levels high enough to allow a small patch to deliver a night-time melatonin puls ...

    SBIR Phase II 2002 Department of Health and Human Services
  10. A NEW METHOD FOR TREATING SLEEP DISORDERS

    Amount: $0.00

    DESCRIPTION (provided by applicant): BIOTEK has developed a transdermal melatonin formulation capable of producing flux levels high enough to allow a small patch to deliver a night-time melatonin puls ...

    SBIR Phase I 2002 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government